{"id":"W2138602439","doi":"10.1200/jco.2003.08.137","title":"Risk of Acute Leukemia Following Epirubicin-Based Adjuvant Chemotherapy: A Report From the National Cancer Institute of Canada Clinical Trials Group","year":2003,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Epirubicin; Medicine; Cyclophosphamide; Internal medicine; Breast cancer; Chemotherapy; Oncology; Cancer; Leukemia; Fluorouracil; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0121119,0.0001782504,0.001877951,0.00002670773,0.00006572463,0.000003534606,0.0002813187,0.0003508148,0.00004048002],"category_scores_gemma":[0.01762472,0.0001086368,0.001165645,0.00009615429,0.0003252511,0.000007660093,0.00004115432,0.0004541753,2.360247e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002387254,"about_ca_system_score_gemma":0.0139345,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02350761,"about_ca_topic_score_gemma":0.06846876,"domain_scores_codex":[0.9930116,0.001809908,0.004210681,0.0002770374,0.0004990022,0.0001917688],"domain_scores_gemma":[0.9894277,0.003721486,0.005868631,0.0002483916,0.0005888465,0.0001449706],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006649294,0.001065403,0.8826379,0.00001119329,0.01677363,0.0002908595,0.00004408115,0.0006648442,0.003703852,0.00005209712,0.05166932,0.0364375],"study_design_scores_gemma":[0.0174985,0.002078909,0.7233317,0.0001037729,0.002463876,0.00006690105,0.00006067723,0.00003654723,0.007126715,0.0004445016,0.2465786,0.0002092965],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897544,0.001929174,0.0005802211,0.002996582,0.003873371,0.0001895429,0.0001907474,0.000001706506,0.0004842399],"genre_scores_gemma":[0.9914194,0.001695007,0.002801806,0.002624312,0.001367618,0.000010162,0.00001939846,0.00001536941,0.0000468689],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1949093,"threshold_uncertainty_score":0.9916556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1163945546688702,"score_gpt":0.4745238978335926,"score_spread":0.3581293431647224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}